Women with polycystic ovary syndrome have increased plasma chitotriosidase activity: A pathophysiological link between inflammation and impaired insulin sensitivity?

Experimental and Clinical Endocrinology and Diabetes

Volumn 120, Issue 5, 2012, Pages 261-265

  Aydogdu, A ^a   Tasci, I ^a   Tapan, S ^a   Sonmez, A ^a   Aydogan, U ^a   Akbulut, H ^a   Uckaya, G ^a   Aydogdu, S ^b   Basaran, Y ^a   Meric, C ^a   Taslipinar, A ^a   Kurt, I ^a   Azal, O ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

^b Mevki Hospital   (Turkey)

Author keywords

chitotriosidase activity; inflammation; insulin resistance; polycystic ovary syndrome

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; CHITOTRIOSIDASE; HIGH SENSITIVITY C REACTIVE PROTEIN; TESTOSTERONE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGE; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVITY; ENZYME IMMUNOASSAY; FEMALE; FLUORESCENCE ANALYSIS; HOMEOSTASIS MODEL ASSESSMENT OF INSULIN RESISTANCE; HUMAN; INFLAMMATION; INSULIN RESISTANCE; MATHEMATICAL MODEL; OVARY POLYCYSTIC DISEASE; PATHOPHYSIOLOGY; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TESTOSTERONE BLOOD LEVEL; WAIST HIP RATIO;

ADIPONECTIN; C-REACTIVE PROTEIN; FEMALE; HEXOSAMINIDASES; HUMANS; INFLAMMATION; INSULIN RESISTANCE; LINEAR MODELS; POLYCYSTIC OVARY SYNDROME; WAIST-HIP RATIO; YOUNG ADULT;

EID: 84861341258     PISSN: 09477349     EISSN: 14393646     Source Type: Journal    
DOI: 10.1055/s-0032-1309010     Document Type: Article

References (32)

1. Aerts J M, Ottenhoff R, Powlson A S et al. Pharmacological inhibition of glucosylceramide synthase enhances insulin sensitivity. Diabetes: 2007; 56 1341 1349 (Pubitemid 46715620)
2. Andersson C X, Gustafson B, Hammarstedt A et al. Inflamed adipose tissue, insulin resistance and vascular injury. Diabetes Metab Res Rev: 2008; 24 595 603
3. Bloomgarden Z T. Inflammation and insulin resistance. Diabetes Care: 2003; 26 1922 1926 (Pubitemid 36929145)
4. Boot R G, Renkema G H, Strijland A et al. Cloning of a cDNA encoding chitotriosidase, a human chitinase produced by macrophages. J Biol Chem: 1995; 270 26252 26256
5. Bourlier V, Bouloumie A. Role of macrophage tissue infiltration in obesity and insulin resistance. Diabetes Metab: 2009; 35 251 260
6. Brinkman J, Wijburg F A, Hollak C E et al. Plasma chitotriosidase and CCL18: early biochemical surrogate markers in type B Niemann-Pick disease. J Inherit Metab Dis: 2005; 28 13 20 (Pubitemid 40253980)
7. Canudas J, Cenarro A, Civeira F et al. Chitotriosidase genotype and serum activity in subjects with combined hyperlipidemia: effect of the lipid-lowering agents, atorvastatin and bezafibrate. Metabolism: 2001; 50 447 450 (Pubitemid 32321954)
8. Corssmit E P, Hollak C E, Endert E et al. Increased basal glucose production in type 1 Gaucher's disease. J Clin Endocrinol Metab: 1995; 80 2653 2657
9. Dunaif A, Finegood D T. Beta-cell dysfunction independent of obesity and glucose intolerance in the polycystic ovary syndrome. J Clin Endocrinol Metab: 1996; 81 942 947 (Pubitemid 26083951)
10. Ghauharali-van der Vlugt K, Langeveld M, Poppema A et al. Prominent increase in plasma ganglioside GM3 is associated with clinical manifestations of type I Gaucher disease. Clin Chim Acta: 2008; 389 109 113
11. Goodarzi M O, Erickson S, Port S C et al. beta-Cell function: a key pathological determinant in polycystic ovary syndrome. J Clin Endocrinol Metab: 2005; 90 310 315 (Pubitemid 40116673)
12. Guo Y, He W, Boer A M et al. Elevated plasma chitotriosidase activity in various lysosomal storage disorders. J Inherit Metab Dis: 1995; 18 717 722 (Pubitemid 26007546)
13. Hahn S, Tan S, Sack S et al. Prevalence of the metabolic syndrome in German women with polycystic ovary syndrome. Exp Clin Endocrinol Diabetes: 2007; 115 130 135 (Pubitemid 46408122)
14. Hollak C E, Vanweely S, Van Oers MH et al. Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease. J Clin Invest: 1994; 93 1288 1292
15. Holmäng A, Svedberg J, Jennische E et al. Effects of testosterone on muscle insulin sensitivity and morphology in female rats. Am J Physiol: 1990; 259 555 560
16. Holte J, Bergh T, Berne C et al. Enhanced early insulin response to glucose in relation to insulin resistance in women with polycystic ovary syndrome and normal glucose tolerance. J Clin Endocrinol Metab: 1994; 78 1052 1058 (Pubitemid 24143022)
17. Kurt I, Abasli D, Cihan M et al. Chitotriosidase levels in healthy elderly subjects. Ann N Y Acad Sci: 2007; 1100 185 188 (Pubitemid 47092651)
18. Langeveld M, Ghauharali K J, Sauerwein H P et al. Gaucher disease, a glycosphingolipid storage disorder, is associated with insulin resistance. J Clin Endocrinol Metab: 2008; 93 845 851 (Pubitemid 351398562)
19. Langeveld M, Scheij S, Dubbelhuis P et al. Very low serum adiponectin levels in patients with type 1 Gaucher disease without overt hyperglycemia. Metabolism: 2007; 56 314 319 (Pubitemid 46209222)
20. Legro R S, Castracane V D, Kauffman R P. Detecting insulin resistance in polycystic ovary syndrome: purposes and pitfalls. Obstet Gynecol Surv: 2004; 59 141 154 (Pubitemid 38140845)
21. Liu S, Navarro G, Mauvais-Jarvis F. Androgen excess produces systemic oxidative stress and predisposes to beta-cell failure in female mice. PLoS One: 2010; 5 11302
22. Malaguarnera L. Chitotriosidase: the yin and yang. Cell Mol Life Sci: 2006; 63 3018 3029 (Pubitemid 46072305)
23. Nilsson O, Mnsson J E, Hkansson G et al. The occurrence of psychosine and other glycolipids in spleen and liver from the three major types of Gaucher's disease. Biochim Biophys Acta: 1982; 14 453 463 (Pubitemid 13198976)
24. O'Meara N M, Blackman J D, Ehrmann D A et al. Defects in beta-cell function in functional ovarian hyperandrogenism. J Clin Endocrinol Metab: 1993; 76 1241 1247 (Pubitemid 23155443)
25. Rotterdam ESHRE/ASRM Sponsored PCOS Consensus Workshop Group Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril: 2004; 81 19 25
26. Saito M, Rosenberg A. The fate of glucosylceramide (glucocerebroside) in genetically impaired (lysosomal beta-glucosidase deficient) Gaucher disease diploid human fibroblasts. J Biol Chem: 1985; 260 2295 2300 (Pubitemid 15105731)
27. Sathyapalan T, Atkin S L. Mediators of inflammation in polycystic ovary syndrome in relation to adiposity. Mediators Inflamm: 2010; 2010 758656
28. Sonmez A, Haymana C, Tapan S et al. Chitotriosidase activity predicts endothelial dysfunction in type-2 diabetes mellitus. Endocrine: 2010; 37 455 459
29. Tagami S, Inokuchi Ji J, Kabayama K et al. Ganglioside GM3 participates in the pathological conditions of insulin resistance. J Biol Chem: 2002; 277 3085 3092 (Pubitemid 34953168)
30. Yamashita T, Hashiramoto A, Haluzik M et al. Enhanced insulin sensitivity in mice lacking ganglioside GM3. Proc Natl Acad Sci USA: 2003; 100 3445 3449 (Pubitemid 36356603)
31. Yew N S, Zhao H, Hong E G et al. Increased hepatic insulin action in diet-induced obese mice following inhibition of glucosylceramide synthase. PLoS One: 2010; 21 11239
32. Zhao H, Przybylska M, Wu I H et al. Inhibiting glycosphingolipid synthesis improves glycemic control and insulin sensitivity in animal models of type 2 diabetes. Diabetes: 2007; 56 1210 1218 (Pubitemid 46715599)